GAVeCeLT 2026: Numantec at the Congress Dedicated to Vascular Access

Numantec a GAVeCeLT 2026

The Numantec Group will attend the 2026 GAVeCeLT National Congress, taking place in Rome from 1 to 3 December. The event is one of Italy’s leading gatherings for healthcare professionals involved in vascular access insertion and management.

The three-day congress will focus on the latest scientific developments, discussions among specialists and advances in the technologies and techniques shaping modern clinical practice.

Numantec at GAVeCeLT 2026: Technology, Training and Professional Exchange

Numantec’s participation in the GAVeCeLT Congress reflects the Group’s ongoing commitment to fostering dialogue between technological innovation, professional expertise and the demands of clinical practice.

The growing range of specialised devices offers healthcare professionals more options, but also makes it increasingly important to understand their features, clinical indications and proper use. Alongside the development and distribution of vascular access solutions, Numantec therefore places particular emphasis on professional training and continuing education.

The congress will provide an opportunity to showcase the Group’s product range, engage directly with industry specialists and gain a deeper understanding of the challenges healthcare facilities face in their day-to-day practice.

From 1 to 3 December, the Numantec team will be available at the Group’s stand in the foyer to present its solutions and provide information on the features and applications of its devices.

Numantec’s participation in GAVeCeLT will also include a workshop dedicated to ProV Midline ST, developed to meet clinical needs requiring an alternative to conventional short peripheral catheters. The workshop will take place on Thursday 3 December, from 1:00 pm to 1:30 pm, in the Michele Ruggieri A Room (Level -1).

ProV Midline ST: The Health Line Mini-Midline in the Spotlight

Numantec’s workshop will focus on ProV Midline ST, a long peripheral catheter developed to bridge the gap between short peripheral intravenous catheters (PIVCs) and traditional Midlines.

The device is intended for peripheral venous access for periods of less than 30 days and may be considered when the condition of the patient’s veins or treatment requirements call for more stable and longer-lasting access than a short PIVC can provide.

The workshop will offer an opportunity to explore the design features of ProV Midline ST and its role in vascular access management, with particular emphasis on how device characteristics, insertion technique and appropriate device selection relate to one another.

Numantec invites healthcare professionals attending GAVeCeLT 2026 (official website) to visit its exhibition stand and take part in the workshop dedicated to ProV Midline ST.